Breakdown | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|
Income Statement | |||||
Total Revenue | 5.31B | 4.90B | 4.63B | 4.25B | 3.46B |
Gross Profit | 1.25B | 1.03B | 939.81M | 946.98M | 711.00M |
EBITDA | 488.50M | 456.45M | 464.76M | 502.74M | 396.08M |
Net Income | 306.91M | 161.79M | 203.83M | 291.20M | 214.51M |
Balance Sheet | |||||
Total Assets | 4.13B | 3.99B | 3.99B | 4.12B | 2.02B |
Cash, Cash Equivalents and Short-Term Investments | 183.12M | 65.41M | 40.66M | 135.06M | 71.74M |
Total Debt | 1.28B | 1.43B | 1.51B | 1.71B | 213.65M |
Total Liabilities | 2.29B | 2.32B | 2.44B | 2.64B | 782.88M |
Stockholders Equity | 1.84B | 1.67B | 1.55B | 1.48B | 1.24B |
Cash Flow | |||||
Free Cash Flow | 401.07M | 223.65M | 233.69M | 480.76M | 203.88M |
Operating Cash Flow | 515.26M | 314.34M | 289.84M | 517.32M | 244.59M |
Investing Cash Flow | -129.10M | -80.96M | -54.01M | -1.84B | -44.14M |
Financing Cash Flow | -275.65M | -250.80M | -248.27M | 1.39B | -230.09M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
80 Outperform | $4.14B | 14.61 | 17.36% | 1.63% | 5.29% | 31.95% | |
75 Outperform | $2.96B | 38.04 | 4.30% | 2.14% | 3.52% | -67.27% | |
74 Outperform | $4.23B | 52.93 | 6.25% | ― | 32.27% | -40.50% | |
71 Outperform | $11.37B | 33.39 | 11.77% | 0.93% | -3.47% | -45.03% | |
65 Neutral | $11.16B | 15.86 | 5.39% | 1.92% | 3.11% | -24.90% | |
61 Neutral | $3.11B | 21.43 | 7.15% | 0.80% | 4.18% | 18.93% | |
60 Neutral | $3.20B | 549.40 | -13.59% | ― | 37.97% | -499.29% |
On June 10, 2025, Maximus, Inc. amended its By-laws to enhance disclosure requirements for shareholders proposing director nominations or business at meetings. These changes include detailed disclosure of stock ownership, performance-related fees, and material relationships, as well as compliance certifications with applicable laws. The amendments also limit the number of board nominees a shareholder can propose, prohibit substitute nominations without notice, and require updates to shareholder information. Additionally, the By-laws now align with Virginia Stock Corporation Act provisions and include technical updates.
The most recent analyst rating on (MMS) stock is a Buy with a $90.00 price target. To see the full list of analyst forecasts on Maximus stock, see the MMS Stock Forecast page.